| EMT, CTCs and CSCs in tumor relapse and drug-resistance A Mitra, L Mishra, S Li Oncotarget 85 (10), 91, 2015 | 515 | 2015 |
| Technologies for deriving primary tumor cells for use in personalized cancer therapy A Mitra, L Mishra, S Li Trends in biotechnology 31 (6), 347-354, 2013 | 250 | 2013 |
| Epithelial–mesenchymal transitioned circulating tumor cells capture for detecting tumor progression A Satelli, A Mitra, Z Brownlee, X Xia, S Bellister, MJ Overman, S Kopetz, ... Clinical Cancer Research 21 (4), 899-906, 2015 | 242 | 2015 |
| Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule- and Cell-Surface Vimentin-Based Methods for Monitoring Breast Cancer Therapeutic … QHMSL Arun Satelli, Zachary Brownlee, Abhishek Mitra Clinical Chemistry, 2014 | 196* | 2014 |
| Universal marker and detection tool for human sarcoma circulating tumor cells A Satelli, A Mitra, JJ Cutrera, M Devarie, X Xia, DR Ingram, D Dibra, ... Cancer research 74 (6), 1645-1650, 2014 | 172 | 2014 |
| EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression A Satelli, I Batth, Z Brownlee, A Mitra, S Zhou, H Noh, CR Rojas, H Li, ... Oncotarget 8 (30), 49329, 2017 | 150 | 2017 |
| IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice SL Abhisek Mitra, Arun Satelli, Jun Yan, Xueqing Xia, Christopher Hunter ... Hepatology, 2014 | 116 | 2014 |
| An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer R Chatterjee, A Mitra International immunopharmacology 24 (2), 335-345, 2015 | 114 | 2015 |
| Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers A Mitra, A Satelli, X Xia, J Cutrera, L Mishra, S Li International journal of cancer 137 (2), 491-496, 2015 | 99 | 2015 |
| Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine IS Batth, A Mitra, S Manier, IM Ghobrial, D Menter, S Kopetz, S Li Annals of Oncology 28 (3), 468-477, 2017 | 90 | 2017 |
| IL6‐mediated inflammatory loop reprograms normal to epithelial‐mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta … A Mitra, J Yan, X Xia, S Zhou, J Chen, L Mishra, S Li Hepatology 65 (4), 1222-1236, 2017 | 70 | 2017 |
| Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary … A Mitra, JA Ross, G Rodriguez, ZS Nagy, HL Wilson, RA Kirken Journal of Biological Chemistry 287 (20), 16596-16608, 2012 | 57 | 2012 |
| The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment D Albino, G Civenni, S Rossi, A Mitra, CV Catapano, GM Carbone Oncotarget 7 (47), 76756, 2016 | 55 | 2016 |
| TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome J Chen, ZX Yao, JS Chen, YJ Gi, NM Muñoz, S Kundra, HF Herlong, ... The Journal of clinical investigation 126 (2), 527-542, 2016 | 50 | 2016 |
| STAT5 regulation of BCL10 parallels constitutive NFκB activation in lymphoid tumor cells ZS Nagy, MJ LeBaron, JA Ross, A Mitra, H Rui, RA Kirken Molecular cancer 8, 1-16, 2009 | 42 | 2009 |
| CTC analysis: an update on technological progress IS Batth, A Mitra, S Rood, S Kopetz, D Menter, S Li Translational Research 212, 14-25, 2019 | 37 | 2019 |
| Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells J Yan, A Mitra, J Hu, JJ Cutrera, X Xia, T Doetschman, M Gagea, L Mishra, ... Journal of hepatology 64 (5), 1128-1136, 2016 | 36 | 2016 |
| Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice D Dibra, X Xia, A Mitra, JJ Cutrera, G Lozano, S Li Hepatology 63 (3), 1000-1012, 2016 | 32 | 2016 |
| Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients IS Batth, L Dao, A Satelli, A Mitra, S Yi, H Noh, H Li, Z Brownlee, S Zhou, ... International journal of cancer 147 (12), 3550-3559, 2020 | 29 | 2020 |
| Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo D Dibra, A Mitra, M Newman, X Xia, JJ Cutrera, M Gagea, ES Kleinerman, ... Clinical Cancer Research 22 (15), 3876-3883, 2016 | 22 | 2016 |
Lopa MishraProfessor of Medicine Merinoff Endowed Chair, and Co-Director, The Institute for BioelectronicVerified email at northwell.edu
